Results by group11

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 11 of 11

Outcome	Group	Category	Value	Spread	Units
Patient Tolerance of Conivaptan	Conivaptan Treatment Group	Abnormal Seizure Activity	0		Participants
Patient Tolerance of Conivaptan	Conivaptan Treatment Group	Abnormal Lab Values	0		Participants
Patient Tolerance of Conivaptan	Conivaptan Treatment Group	Infections	1		Participants
Patient Tolerance of Conivaptan	Conivaptan Treatment Group	Drug-related Adverse Events	0		Participants
In-hospital Mortality	Conivaptan Treatment Group		0		Participants
Change in Cerebral Edema	Conivaptan Treatment Group		-37.1	Full Range -96.2 to 70.7	percentage of change from baseline
Cost	Conivaptan Treatment Group		14.4	Full Range 9.7 to 28.9	days
Cost	Conivaptan Treatment Group	EVD/bolt or surgical procedures	0		Participants
Cost	Conivaptan Treatment Group	Lines or tracheostomy/PEG	7		Participants
Cost	Conivaptan Treatment Group	Ventilator	1		Participants
Modified Rankin Scale (mRS) Score	Conivaptan Treatment Group		5	Full Range 3 to 5	score on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03000283/results